St. Jude Medical Inc. sees an opportunity for neuromodulators to play an important role in fighting the opioid epidemic. But physicians first need to be retrained on new treatment algorithms for pain management, a company official says.
Over the past decade, opioid abuse and overdose has become a major public-health concern to the extent that the Centers for Disease Control and Prevention has declared it an epidemic.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?